Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation
CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies; however, its efficacy in solid tumors remains constrained. In this study, we demonstrate that Lentinan (LTN), an active polysaccharide derived from Lentinula edodes, potently enhances CAR-T cell function aga...
Saved in:
| Main Authors: | Xiangyun Niu, Pengchao Zhang, Zhongming Liu, Yexiao Tang, Shu Xu, Xiaochun Wan, Zhiming Xu, Guizhong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1605488/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD28 is superior to 4-1BB costimulation in generating CAR-NK cells for tumor immunotherapy
by: Pengchao Zhang, et al.
Published: (2025-03-01) -
Effectiveness, Limitations, and Future Perspectives of CAR-T Cell Therapy in Solid Tumor Treatment: A Narrative Review
by: Dmytro Kowalczuk, et al.
Published: (2025-05-01) -
Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR‐T‐Cell Therapy
by: Zhanna Zhang, et al.
Published: (2024-10-01) -
Targeting B7-H3 in solid tumors: Development and evaluation of novel CAR-T Cell therapy
by: Ning Li, et al.
Published: (2025-05-01) -
Application of lentinan in suppression of Marek's disease virus infection
by: Qiming Gao, et al.
Published: (2024-12-01)